ATRC Relative Valuation
ATRC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ATRC is overvalued; if below, it's undervalued.
Historical Valuation
AtriCure Inc (ATRC) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.74 is considered Undervalued compared with the five-year average of -49.83. The fair price of AtriCure Inc (ATRC) is between 35.95 to 90.82 according to relative valuation methord. Compared to the current price of 29.26 USD , AtriCure Inc is Undervalued By 18.62%.
Relative Value
Fair Zone
35.95-90.82
Current Price：29.26
18.62%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.24
P/B
Median3y
3.82
Median5y
4.87
0.77
FCF Yield
Median3y
-0.99
Median5y
-1.06
Competitors Valuation Multiple
The average P/S ratio for ATRC's competitors is 3.94, providing a benchmark for relative valuation. AtriCure Inc Corp (ATRC) exhibits a P/S ratio of 2.74, which is -30.63% above the industry average. Given its robust revenue growth of 13.57%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is AtriCure Inc (ATRC) currently overvalued or undervalued?
What is AtriCure Inc (ATRC) fair value?
How does ATRC's valuation metrics compare to the industry average?
What is the current P/B ratio for AtriCure Inc (ATRC) as of Jul 19 2025?
What is the current FCF Yield for AtriCure Inc (ATRC) as of Jul 19 2025?
What is the current Forward P/E ratio for AtriCure Inc (ATRC) as of Jul 19 2025?